Insider Cluster (2 insiders) ·Filed Jul 16, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $221K total
Actionable Insight • Neutral

The insider selling is routine and immaterial. Monitor next quarterly earnings for any fundamental changes, but this cluster alone does not warrant a directional trade.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
UTHR ▼ -5.60% at T+20d
NEUTRAL call ✗ call lost -5.60% · α vs SPY -9.22% · entry $529.05 → $499.42
Next anchor: T+60d in 6d
Latest observation: T+52 +0.11% FF3 residual α
Entry anchored
Jul 15, 03:59 PM ET
via exchange tick
T+1d
+1.25%
call +1.25% · α +2.24%
$535.67
settled 3mo ago
T+5d
+0.09%
call +0.09% · α +1.76%
$529.53
settled 2mo ago
T+20d
-5.60%
call -5.60% · α -9.22%
$499.42
settled 7w ago
T+60d
—
call — · α —
—
in 6d

Price Chart

Loading chart...

Executive Summary

Insider selling by CEO Martine Rothblatt and EVP/General Counsel Paul Mahon totaling $8.2M, but representing only 0.036% of UTHR's $22.5B market cap. Sales follow option exercises and are likely for tax withholding and liquidity diversification, consistent with routine insider activity. No bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$8.2M
Insiders
2

Key Facts

  • CEO Martine Rothblatt and EVP/General Counsel Paul Mahon sold shares after exercising stock options in a 7-day window.
  • Total open-market sales of approximately $8.18M, equivalent to 0.036% of market cap.
  • Sales are liquidity-driven and tax-related, not a reflection of deteriorating fundamentals.
  • No 10b5-1 plan indicated; the cluster is small relative to company size and insider holdings.

Financial Impact

Total insider selling of $8.2M, insignificant relative to $22.5B market cap

insider holdings

Risk Factors

  • No material risk; the selling is small and typical for option exercises

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1784278922212
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 17, 2026